As of 2025-09-17, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (48.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -8970.0%.
The range of the Relative Valuation is (46.25) - (49.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 19.4x | 18.8x |
| Forward P/E multiples | 18.2x - 22.1x | 19.6x |
| Fair Price | (46.25) - (49.26) | (48.79) |
| Upside | -8509.8% - -9055.6% | -8970.0% |
| Date | P/E |